Table of Contents

company-logo

Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema. It also engages in the development of rhC1INH for the treatment of pre-eclampsia, acute kidney injury, and COVID-19; leniolisib, a phosphoinositide 3-kinase delta (PI3K delta) to treat patients with activated PI3K delta syndrome; and alpha-glucosidase therapy for the treatment of pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of hereditary angioedema. Pharming Group N.V. is headquartered in Leiden, the Netherlands.

Pharming Dividend Announcement

• Pharming does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Pharming dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Pharming Dividend History

Pharming Dividend Yield

Pharming current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Pharming stock? Use our calculator to estimate your expected dividend yield:

Pharming Financial Ratios

P/E ratio-31.22
PEG ratio-0.80
P/B ratio2.40
ROE-8.08%
Payout ratio0.00%
Current ratio3.53
Quick ratio2.76
Cash Ratio0.76

Pharming Dividend FAQ

Does Pharming stock pay dividends?
Pharming does not currently pay dividends to its shareholders.
Has Pharming ever paid a dividend?
No, Pharming has no a history of paying dividends to its shareholders. Pharming is not known for its dividend payments.
Why doesn't Pharming pay dividends?
There are several potential reasons why Pharming would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Pharming ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Pharming has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Pharming a dividend aristocrat?
Pharming is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Pharming a dividend king?
Pharming is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Pharming a dividend stock?
No, Pharming is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Pharming stocks?
To buy Pharming you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Pharming stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.